Biogen Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€181.30
Target price
09.09.25
€264.32
Performance (%)
-32.63%
End price
10.09.25
€122.15
Summary
This prediction ended on 10.09.25 with a price of €122.15. Massive losses of -32.63% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.445% | -2.445% | 47.823% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten

